GLYZIMAC OD 60 TABLET

Product Description

GLYZIMAC OD 60 TABLET is a powerful oral anti-diabetic formulation combining Gliclazide 60mg and Metformin 500mg (Extended Release), designed to provide effective glycemic control in patients with Type 2 Diabetes Mellitus. This dual-action therapy helps improve insulin sensitivity, reduce hepatic glucose production, and stimulate pancreatic insulin secretionall in a once-daily extended-release format for better compliance.

Manufactured under WHO-GMP certified conditions, GLYZIMAC OD 60 is an ideal addition to the product portfolio of medical distributors, retailers, and bulk pharmaceutical suppliers seeking high-demand, chronic care medicines.

Key Benefits:

• Dual-action anti-diabetic therapy with Gliclazide + Metformin

• Extended-release formula for stable, all-day blood sugar control

• Reduces fasting and postprandial glucose levels

• Improves insulin sensitivity and beta-cell function

• Once-daily dosage ensures better patient adherence

Applications:

• Management of Type 2 Diabetes Mellitus

• Ideal for use in primary care, endocrinology, and diabetes clinics

• Suitable for long-term chronic care prescriptions

Why Choose GLYZIMAC OD 60 TABLET?

• High-demand oral anti-diabetic combination

• Consistent quality and therapeutic efficacy

• Excellent profit margins for B2B distributors and retailers

• Available for bulk orders, PCD pharma franchise, and third-party manufacturing